TCBP Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform...

Stats
Today's Volume	142 286
Average Volume	4.72M
Market Cap	1.51M
EPS	$0 ( 2022-12-12 )
Next earnings date	( $0 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0700
ATR14	$0.0130 (0.83%)

Insider Trading

Date	Person	Action	Amount	type
2022-11-30	Randall Diana Elizabeth	Buy	70 000	Series B Warrants
2022-11-30	Randall Mark Edward	Buy	70 000	Ordinary Shares [ADS]
2022-11-30	Randall Mark Edward	Buy	70 000	Series B Warrants
2022-11-30	Randall Kenneth Edward	Buy	70 000	Ordinary Shares [ADS]
2022-11-30	Randall Kenneth Edward	Buy	70 000	Series B Warrants

INSIDER POWER
74.83
Last 15 transactions
Buy: 790 803 \| Sell: 5 306 464

Volume Correlation

Long: 0.21 (neutral)

Short: 0.27 (neutral)

Signal:(46.595) Neutral

TC Biopharm (Holdings) Correlation

10 Most Positive Correlations
NEPT	0.903
VSTA	0.891
NOTV	0.886
POWW	0.886
TTCF	0.885
INVE	0.878
INFI	0.878
ACET	0.877
PLXP	0.876
VIH	0.875

10 Most Negative Correlations
CCRC	-0.904
TUR	-0.895
IMMR	-0.894
MGI	-0.887
TVTY	-0.874
IBEX	-0.862
BILI	-0.854
ROST	-0.853
PBFS	-0.853
ACLX	-0.852

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

TC Biopharm (Holdings) Correlation - Currency/Commodity

-0.12
( neutral )

0.50
( weak )

0.00
( neutral )

0.10
( neutral )

-0.45
( neutral )

0.34
( neutral )

TC Biopharm (Holdings) Financials

Annual	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-19.12

Q3	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Q2	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Q1	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

TC Biopharm (Holdings)

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.